Go to deals
Healthcare

Laboratoire Tilman has acquired Promogen

The shareholders of Promogen have sold the company to Laboratoire Tilman.

Founded in 1956, Laboratoire Tilman is a Belgium pharmaceutical laboratory specialized in the development, production and marketing of phytotherapy products and is the leader in the field of medicinal plants in Belgium. The company offers a range of more than 100 natural herbal solutions sold in over 30 countries, including best-selling products such as Flexofytol, Sedistress and Antimetil.

Founded in 2012, Promogen is an external independent French pharmaceutical network that promotes, sells and distributes a diverse portfolio, which includes medicines, medical devices, food supplements and cosmetics, through four brands, in the rheumatology, well-being, dermo-cosmetics, wound healing and fertility therapeutic areas. Promogen distributes its products to over 9,000 pharmacies and drugstores in France, through an in-house sales force of approximately 40 representatives.

Oaklins’ team in France acted as advisor to the shareholders of Laboratoire Tilman in this transaction.

Service
M&A buy-side
Parties

Talk to the deal team

 Ludovic  Beaulieu

Ludovic Beaulieu

Partner
Paris, France
Oaklins France
 Quentin  Boissinot

Quentin Boissinot

Analyst
Paris, France
Oaklins France

Related deals

Presmed Australia has been acquired by ICG
Private Equity | Healthcare

Presmed Australia has been acquired by ICG

Advanced Health Limited has sold Presmed Australia Pty Ltd (PMA) to ICG.

Learn more
Pia Mater, a social services firm, has been acquired by SAT Heath
Private Equity | Healthcare

Pia Mater, a social services firm, has been acquired by SAT Heath

The founders of Pia Mater Ltd. have sold the company to SAT Health.

Learn more
DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm
Private Equity | Healthcare

DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm

The owner of DIAGOMICS has sold the company to ZytoMax GmbH.

Learn more